Ekso Bionics HoldingsEKSO -0.42%32 Days Payable is 151.37 as of Mar. 2026, which is 10% above its 10-year median of 136.99. GuruFocus rates EKSO with a GF Score™ of 32/100 and a GF Value™ of $4.36 (Significantly Overvalued). The stock has 10 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Ekso Bionics Holdings ranks better than 70.44% on this metric.
Ekso Bionics Holdings Days Payable Historical Data
* Premium members only.
The historical data trend for Ekso Bionics Holdings's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Ekso Bionics Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ekso Bionics Holdings Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ekso Bionics Holdings's Days Payable distribution charts can be found below:
* The bar in red indicates where Ekso Bionics Holdings's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Ekso Bionics Holdings's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ekso Bionics Holdings (EKSO) has a Days Payable of 151.37 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Ekso Bionics Holdings and its competitors. This is 10% above median its historical median of 136.99. Over the past decade, Ekso Bionics Holdings' Days Payable has ranged from 73.72 to 187.00. According to the industry distribution chart, Ekso Bionics Holdings ranks #235 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 29.6%.
Is Ekso Bionics Holdings' Days Payable too high?
Ekso Bionics Holdings' current Days Payable of 151.37 is 10% above median its 10-year median of 136.99. Over the past 10 years, this metric has ranged from a low of 73.72 to a high of 187.00. The Medical Devices & Instruments industry median Days Payable is 68.07. Ekso Bionics Holdings' value of 151.37 is 122.4% above this industry median. Based on the distribution chart, Ekso Bionics Holdings ranks #235 out of 795 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Ekso Bionics Holdings has a GF Score™ of 32/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ekso Bionics Holdings' Days Payable compare to POCI and HBIO?
According to the Medical Devices & Instruments industry distribution chart, Ekso Bionics Holdings ranks #235 out of 795 companies for Days Payable. This puts Ekso Bionics Holdings in the upper half of its industry. The industry median Days Payable is 68.07. Ekso Bionics Holdings' value of 151.37 is 122.4% above this benchmark. Historically, Ekso Bionics Holdings' own Days Payable has ranged from 73.72 to 187.00 over the past decade. While the company's 10-year median is 136.99 vs. the industry median of 68.07, Ekso Bionics Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.07, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ekso Bionics Holdings's current Days Payable of 151.37 is 122.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Ekso Bionics Holdings and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ekso Bionics Holdings's current Days Payable is 151.37, which is 10% above median its own 10-year median of 136.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ekso Bionics Holdings stock overvalued right now?
Based on GuruFocus' analysis, Ekso Bionics Holdings (EKSO) is currently considered Significantly Overvalued. The stock's GF Value™ is $4.36, compared to a current price of $11.65 — trading 167.2% above its estimated fair value. The current Days Payable is 151.37, which is 10% above median its 10-year median of 136.99 and 122.4% above the Medical Devices & Instruments industry median of 68.07. Ekso Bionics Holdings' overall GF Score™ is 32/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Ekso Bionics Holdings (EKSO), the current Days Payable is 151.37 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ekso Bionics Holdings (EKSO) Overvalued in 2026?
Based on GuruFocus' analysis, Ekso Bionics Holdings stock appears to be overvalued.
The current stock price of $11.65 is trading 167.2% above its estimated GF Value™ of $4.36.
GuruFocus considers Ekso Bionics Holdings to be Significantly Overvalued.
Key valuation signals for EKSO:
Days Payable: 151.37 (10% above median its 10-year median of 136.99)
GF Value™: $4.36 vs. price of $11.65 (167.2% above fair value)
Industry Position: 122.4% above the Medical Devices & Instruments median (#235 of 795)
No single metric tells the full story. See the EKSO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.
32GF Score
Get the complete analysis for EKSO
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EKSO has been successfully added to your 
